Andrew Natenshon

Andrew (Drew) Natenshon is the Portfolio Head at Moderna, leading global public health and pandemic preparedness programs. Andrew (Drew) has a background in infectious disease vaccine development and has held various leadership roles at companies like Genocea Biosciences, Seqirus, and Novartis Vaccines. With a strong educational background, including degrees from The Johns Hopkins University and Dartmouth College, Natenshon also has experience in strategic consulting at McKinsey & Company and advisory roles at the Bill and Melinda Gates Foundation.